SBI Healthcare Opportunities Growth Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹5,000

SBI Healthcare Opportunities Growth Direct Plan

NAV
₹479.0831
-1.11%
(16 Jan)
AUM
3,989 Cr
TER
0.91%
Risk
Very High Risk
Insights
Net Asset Value (NAV) is below its 200 days moving average
Asset Under Management (AUM) is in the top 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
+18.8%
+18.3%
+16.6%
+7.8%
+1.0%
3Y
+29.9%
+31.1%
+29.8%
+31.3%
+24.5%
5Y
NA
+28.7%
+29.6%
+22.3%
+16.7%
ALL
+26.8%
+17.0%
+12.2%
+17.8%
+17.2%
VOL
14.3%
19.6%
20.0%
16.1%
16.2%
TER
1.0%
0.9%
0.8%
0.5%
0.9%
AUM
₹3,082 Cr
₹1,449 Cr
₹5,817 Cr
₹8,304 Cr
₹3,989 Cr
INFO
1.87
0.87
0.61
1.11
1.06
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
SBI Healthcare Opportunities (G)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 31st Dec
Top holdings
Sun Pharmaceuticals Industries Ltd
11.6%
Divi's Laboratories Ltd
7.1%
Max Healthcare Institute Ltd Ordinary Shares
5.2%
Lupin Ltd
4.4%
Laurus Labs Ltd
3.9%
Torrent Pharmaceuticals Ltd
3.9%
Acutaas Chemicals Ltd
3.8%
Cipla Ltd
3.8%
Lonza Group Ltd ADR
3.6%
Treps
3.5%
Top industry exposure
Healthcare
89.7%
Basic Materials
6.9%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹5,000
Additional lumpsum
₹1,000
Portfolio turnover
12%
Lock-in period
-
Exit load
• 0.5% for redemption within 15 days
Fund objective
To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Fund manager(s)
Tanmaya Desai

FAQs